Study Stopped
Abandoned project
Iatrogenic Drug Risk in People Over 75, With or Without Cognitive Disorders, From an Inventory of Their Family Pharmacy
RIMPAP
2 other identifiers
observational
N/A
0 countries
N/A
Brief Summary
Many hospitalizations or emergency room visits are due to problems of iatrogenic medication, especially in elderly patients who are very often polymedicated. Moreover, they are more at risk because of fragility. This has an important socio-economic impact. It therefore seems important to act upstream of these adverse events and a review of the drugs available in the homes of elderly patients seems a good starting point.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2019
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 21, 2018
CompletedFirst Posted
Study publicly available on registry
September 27, 2018
CompletedStudy Start
First participant enrolled
June 28, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 28, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 28, 2019
CompletedSeptember 26, 2019
September 1, 2019
Same day
September 21, 2018
September 25, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Iatrogenic drug risk in patients' homes
Description of potential drug contraindications and potential unadvisable drug interactions highlighted from the analysis of the family pharmacy by Theriaque databased
At the inclusion (baseline)
Study Arms (1)
Elderly
Patient over 75 years seen with the mobile extra hospital geriatric team
Interventions
Eligibility Criteria
Patient over 75 years seen with the mobile extra hospital geriatric team
You may qualify if:
- Patient over 75 years with or without cognitive disorders
You may not qualify if:
- Refusal to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Julie BOURGUEIL, MD
University Hospital, Tours
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 21, 2018
First Posted
September 27, 2018
Study Start
June 28, 2019
Primary Completion
June 28, 2019
Study Completion
June 28, 2019
Last Updated
September 26, 2019
Record last verified: 2019-09